Rafael Pulido

6.8k total citations · 1 hit paper
130 papers, 5.3k citations indexed

About

Rafael Pulido is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Rafael Pulido has authored 130 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 99 papers in Molecular Biology, 36 papers in Immunology and 25 papers in Oncology. Recurrent topics in Rafael Pulido's work include Protein Tyrosine Phosphatases (43 papers), PI3K/AKT/mTOR signaling in cancer (37 papers) and Protein Kinase Regulation and GTPase Signaling (22 papers). Rafael Pulido is often cited by papers focused on Protein Tyrosine Phosphatases (43 papers), PI3K/AKT/mTOR signaling in cancer (37 papers) and Protein Kinase Regulation and GTPase Signaling (22 papers). Rafael Pulido collaborates with scholars based in Spain, Norway and United Kingdom. Rafael Pulido's co-authors include Josema Torres, Francisco Sánchez‐Madrid, Caroline E. Nunes‐Xavier, Miguel R. Campanero, Wiljan Hendriks, Amparo Andrés‐Pons, Carmen Blanco‐Aparicio, Manuel O. Landázuri, Miguel Valiente and José I. López and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Experimental Medicine.

In The Last Decade

Rafael Pulido

127 papers receiving 5.2k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Tumor Suppressor PTEN Is Phosphorylated by the Protein Kinase CK2 at Its C Terminus

2001 536 citations Rafael Pulido et al. Journal of Biological Chemistry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rafael Pulido Spain	38	3.6k	1.4k	843	810	586	130	5.3k
Ana C. Carrera Spain	42	3.3k 0.9×	1.6k 1.2×	1.1k 1.3×	451 0.6×	672 1.1×	96	5.4k
Masabumi Shibuya Japan	41	4.6k 1.3×	990 0.7×	1.7k 2.0×	472 0.6×	723 1.2×	77	6.6k
Connie L. Sommers United States	33	1.9k 0.5×	2.4k 1.7×	1.1k 1.4×	597 0.7×	483 0.8×	59	4.7k
Shulamit Katzav Israel	30	2.1k 0.6×	1.3k 0.9×	940 1.1×	416 0.5×	476 0.8×	73	3.8k
Alessandra Eva Italy	35	3.5k 1.0×	1.1k 0.8×	1.0k 1.2×	264 0.3×	1.1k 1.9×	111	5.5k
Reiner Lammers Germany	39	4.6k 1.3×	1.3k 0.9×	1.1k 1.3×	349 0.4×	981 1.7×	75	6.1k
Brad St. Croix United States	32	4.1k 1.1×	761 0.5×	1.8k 2.2×	581 0.7×	697 1.2×	58	6.0k
Brian Duckworth United States	12	3.4k 0.9×	926 0.7×	914 1.1×	399 0.5×	1.2k 2.0×	15	4.9k
Alexander Y. Tsygankov United States	30	2.1k 0.6×	1.0k 0.7×	939 1.1×	319 0.4×	447 0.8×	88	3.6k
Antonio Postigo Spain	40	5.0k 1.4×	1.3k 0.9×	2.8k 3.3×	586 0.7×	716 1.2×	74	7.7k

Countries citing papers authored by Rafael Pulido

Since Specialization

Citations

This map shows the geographic impact of Rafael Pulido's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rafael Pulido with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rafael Pulido more than expected).

Fields of papers citing papers by Rafael Pulido

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rafael Pulido. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rafael Pulido. The network helps show where Rafael Pulido may publish in the future.

Co-authorship network of co-authors of Rafael Pulido

This figure shows the co-authorship network connecting the top 25 collaborators of Rafael Pulido. A scholar is included among the top collaborators of Rafael Pulido based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rafael Pulido. Rafael Pulido is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lawrie, Charles H., María Armesto, Caroline E. Nunes‐Xavier, et al.. (2025). Fibroblast Activation Protein Alpha (FAP) Expression Is Associated with Disease Recurrence and Poor Response to Tyrosine Kinase Inhibitors in Advanced Clear Cell Renal Cell Carcinoma. International Journal of Molecular Sciences. 26(22). 11112–11112.

Amayra, Imanol, et al.. (2025). Cognitive and Adaptive Functioning of CTNNB1 Syndrome Patients: A Comparison With Autism Spectrum Disorder and Cerebral Palsy. Journal of Intellectual Disability Research. 69(7). 558–568. 1 indexed citations

Amayra, Imanol, et al.. (2025). Novel CTNNB1 Gene Variants in Spanish CTNNB1 Syndrome Patients: Clinical and Psychological Manifestations. Journal of Autism and Developmental Disorders. 1 indexed citations

Kumar, Vikash, Doron Ginsberg, Carlos Romá‐Mateo, et al.. (2024). The lincRNA JUNI regulates the stress-dependent induction of c-Jun, cellular migration and survival through the modulation of the DUSP14-JNK axis. Oncogene. 43(21). 1608–1619. 1 indexed citations

Angulo, J.C., Gorka Larrinaga, Charles H. Lawrie, et al.. (2024). Predicting Survival of Metastatic Clear Cell Renal Cell Cancer Treated with VEGFR-TKI-Based Sequential Therapy. Cancers. 16(16). 2786–2786. 1 indexed citations

Øyjord, Tove, Gunhild M. Mælandsmo, J.C. Angulo, et al.. (2024). Impact of B7-H3 expression on metastasis, immune exhaustion and JAK/STAT and PI3K/AKT pathways in clear cell renal cell carcinoma. OncoImmunology. 13(1). 2419686–2419686. 3 indexed citations

Pulido, Rafael, José I. López, & Caroline E. Nunes‐Xavier. (2024). B7-H3: a robust target for immunotherapy in prostate cancer. Trends in cancer. 10(7). 584–587. 11 indexed citations

Nunes‐Xavier, Caroline E., Laura Zaldumbide, Idoia Martín‐Guerrero, et al.. (2022). Identification and Functional Analysis of a Novel CTNNB1 Mutation in Pediatric Medulloblastoma. Cancers. 14(2). 421–421. 2 indexed citations

Larrinaga, Gorka, et al.. (2021). (Pro)renin Receptor Is a Novel Independent Prognostic Marker in Invasive Urothelial Carcinoma of the Bladder. Cancers. 13(22). 5642–5642. 1 indexed citations

10.

Amo, Laura, Isabel Rodríguez‐Escudero, Asier Erramuzpe, et al.. (2021). A global analysis of the reconstitution of PTEN function by translational readthrough ofPTENpathogenic premature termination codons. Human Mutation. 42(5). 551–566. 13 indexed citations

11.

Nunes‐Xavier, Caroline E., Wanja Kildal, Andreas Kleppe, et al.. (2021). Immune checkpoint B7‐H3 protein expression is associated with poor outcome and androgen receptor status in prostate cancer. The Prostate. 81(12). 838–848. 20 indexed citations

12.

Manini, Claudia, D. Büchser, Roberto Llarena, et al.. (2020). Oligometastatic Prostate Adenocarcinoma. Clinical-Pathologic Study of a Histologically Under-Recognized Prostate Cancer. Journal of Personalized Medicine. 10(4). 265–265. 3 indexed citations

13.

Heras, Javier de las, Ibai Díez, A Cabrera, et al.. (2020). Brain Circuit Alterations and Cognitive Disability in Late-Onset Cobalamin D Disorder. Journal of Clinical Medicine. 9(4). 990–990. 2 indexed citations

14.

Gaafar, Ayman, Caroline E. Nunes‐Xavier, Isabel Guerra, et al.. (2019). Precise definition of PTEN C-terminal epitopes and its implications in clinical oncology. npj Precision Oncology. 3(1). 11–11. 15 indexed citations

15.

Nunes‐Xavier, Caroline E., et al.. (2019). Dual-Specificity Phosphatases in Neuroblastoma Cell Growth and Differentiation. International Journal of Molecular Sciences. 20(5). 1170–1170. 12 indexed citations

16.

Rodríguez‐Escudero, Isabel, et al.. (2019). Expression of Human PTEN-L in a Yeast Heterologous Model Unveils Specific N-Terminal Motifs Controlling PTEN-L Subcellular Localization and Function. Cells. 8(12). 1512–1512. 7 indexed citations

17.

Pulido, Rafael. (2018). PTEN Inhibition in Human Disease Therapy. Molecules. 23(2). 285–285. 58 indexed citations

18.

Gil, Anabel, José I. López, & Rafael Pulido. (2015). Assessing PTEN Subcellular Localization. Methods in molecular biology. 1388. 169–186. 9 indexed citations

19.

Pulido, Rafael, Andrew W. Stoker, & Wiljan Hendriks. (2013). PTPs emerge as PIPs: protein tyrosine phosphatases with lipid-phosphatase activities in human disease. Human Molecular Genetics. 22(R1). R66–R76. 30 indexed citations

20.

Ríos, Pablo, Rocío Cejudo-Marín, Carmen Blanco‐Aparicio, et al.. (2005). ERK2 Shows a Restrictive and Locally Selective Mechanism of Recognition by Its Tyrosine Phosphatase Inactivators Not Shared by Its Activator MEK1. Journal of Biological Chemistry. 280(45). 37885–37894. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact